Increasing haemoglobin oxygen affinity to prevent sickling: abnormal haemoglobin variants as models

Area of Science:

• Biochemistry
• Hematology
• Molecular Biology

Background:

• Sickle cell disease is caused by polymerization of deoxygenated sickle hemoglobin (deoxy-Hb S).
• Increased oxygen affinity of hemoglobin can inhibit deoxy-Hb S polymerization and cell sickling.
• Hemoglobin F (Hb F) is a known inhibitor of deoxy-Hb S polymerization.

Purpose of the Study:

• To investigate two abnormal high oxygen affinity hemoglobins (Hb Bethesda and Hb Radcliffe) as models for anti-sickling agents.
• To predict the effect of chemically modifying hemoglobin to increase oxygen affinity.
• To understand the mechanism of inhibition of deoxy-Hb S polymerization by high oxygen affinity hemoglobins.

Main Methods:

• Studied the ability of Hb Bethesda and Hb Radcliffe to inhibit the polymerization of deoxy-Hb S.
• Quantitatively described the participation of these variants in deoxy-Hb S polymers using an exclusion coefficient (f).
• Qualitatively described their behavior using an exponent of hybridization.

Main Results:

• Hb Bethesda demonstrated potent inhibition of deoxy-Hb S polymerization, similar to Hb F.
• Hb Radcliffe exhibited atypical behavior, with hybrid molecules participating in polymerization as effectively as Hb S.
• The study provides quantitative and qualitative data on the interaction of these variants with deoxy-Hb S.

Conclusions:

• Hb Bethesda serves as a promising model for developing anti-sickling agents that increase oxygen affinity.
• Hb Radcliffe's atypical behavior highlights the complexity of hemoglobin interactions in sickle cell disease.
• These findings have implications for designing novel covalent anti-sickling therapies targeting Hb S.